Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 37, 2007 - Issue 5
164
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Effect of enalapril on the in vitro and in vivo peptidyl cleavage of a potent VLA-4 antagonist

, , , , , & show all
Pages 487-502 | Received 26 Jan 2007, Accepted 05 Mar 2007, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nourollah Ramroodi, Masood Khani, Zohre Ganjali, Mohammad Reza Javan, Nima Sanadgol, Roghayeh Khalseh, Hadi Ravan, Ehsan Sanadgol & Mohammad Abdollahi. (2015) Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis. Immunological Investigations 44:7, pages 694-712.
Read now

Articles from other publishers (9)

Yagmur Tasdemiroglu, McAlister Council-Troche, Miao Chen, Benjamin Ledford, Russell A. Norris, Steven Poelzing, Robert G. Gourdie & Jia-Qiang He. (2024) Degradation of the α-Carboxyl Terminus 11 Peptide: In Vivo and Ex Vivo Impacts of Time, Temperature, Inhibitors, and Gender in Rat . ACS Pharmacology & Translational Science.
Crossref
Tingting He, Daria Giacomini, Alessandra Tolomelli, Monica Baiula & Luca Gentilucci. (2024) Conjecturing about Small-Molecule Agonists and Antagonists of α4β1 Integrin: From Mechanistic Insight to Potential Therapeutic Applications. Biomedicines 12:2, pages 316.
Crossref
Monica Baiula, Michele Anselmi, Francesco Musiani, Alessia Ghidini, Jacopo Carbone, Alberto Caligiana, Andrea Maurizio, Santi Spampinato & Luca Gentilucci. (2023) Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α4β1 Integrin. International Journal of Molecular Sciences 24:11, pages 9588.
Crossref
Michele Anselmi, Monica Baiula, Santi Spampinato, Roberto Artali, Tingting He & Luca Gentilucci. (2023) Design and Pharmacological Characterization of α 4 β 1 Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism . Journal of Medicinal Chemistry.
Crossref
Michele Anselmi, Monica Baiula, Federica Santino, Junwei Zhao, Santi Spampinato, Natalia Calonghi & Luca Gentilucci. (2021) Design of α/β-Hybrid Peptide Ligands of α4β1 Integrin Equipped with a Linkable Side Chain for Chemoselective Biofunctionalization of Microstructured Materials. Biomedicines 9:11, pages 1737.
Crossref
Samantha Deianira Dattoli, Monica Baiula, Rossella De Marco, Andrea Bedini, Michele Anselmi, Luca Gentilucci & Santi Spampinato. (2018) DS‐70, a novel and potent α 4 integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs . British Journal of Pharmacology 175:20, pages 3891-3910.
Crossref
Rossella De Marco, Alessandra Tolomelli, Eusebio Juaristi & Luca Gentilucci. (2016) Integrin Ligands with α/β‐Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects. Medicinal Research Reviews 36:3, pages 389-424.
Crossref
Rossella De Marco, Giacomo Mazzotti, Samantha D. Dattoli, Monica Baiula, Santi Spampinato, Arianna Greco & Luca Gentilucci. (2015) 5‐aminomethyloxazolidine‐2,4‐dione hybrid α/β‐dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists. Peptide Science 104:5, pages 636-649.
Crossref
Samantha D. Dattoli, Rossella De Marco, Monica Baiula, Santi Spampinato, Arianna Greco, Alessandra Tolomelli & Luca Gentilucci. (2014) Synthesis and assay of retro-α4β1 integrin-targeting motifs. European Journal of Medicinal Chemistry 73, pages 225-232.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.